{"id":420,"date":"2020-08-26T05:07:54","date_gmt":"2020-08-26T05:07:54","guid":{"rendered":"http:\/\/model1.caplinpoint.net\/?page_id=420"},"modified":"2026-04-27T10:01:50","modified_gmt":"2026-04-27T10:01:50","slug":"investor-contacts","status":"publish","type":"page","link":"http:\/\/model1.caplinpoint.net\/index.php\/investor-contacts\/","title":{"rendered":"Investor Contacts"},"content":{"rendered":"\n<h3 class=\"has-text-align-center\">CAPLIN POINT LABORATORIES LIMITED<\/h3>\n\n\n\n<p>CONTACT DETAILS OF KEY MANAGERIAL PERSONNEL\u2019S AUTHORISED FOR THE PURPOSE THE DETERMINING THE MATERIALITY OF AN EVENT OR INFORMATION AND MAKING DISCLOSURE TO THE STOCK EXCHANGE .<\/p>\n\n\n\n<p>(Pursuant to Regulation 30(5) of the SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015)<\/p>\n\n\n\n<div class=\"wp-block-columns\">\n<div class=\"wp-block-column\" style=\"flex-basis:66.66%\">\n<figure class=\"wp-block-table is-style-stripes\"><table><tbody><tr style=\"font-family:Roboto;font-size:15px;font-weight:bold;\"><td>S.NO<\/td><td>NAME OF THE KMP<\/td><td>DESIGNATION<\/td><\/tr><tr><td>01<\/td><td>Dr Sridhar Ganesan<\/td><td>Managing Director<\/td><\/tr><tr><td>02<\/td><td>Mr D Muralidharan<\/td><td>Chief Financial Officer<\/td><\/tr><tr><td>03<\/td><td>Mr G Venkatram<\/td><td>General Counsel &amp; Company Secretery<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p><\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column\" style=\"flex-basis:33.33%\">\n<figure class=\"wp-block-table is-style-stripes\"><table class=\"has-fixed-layout\"><tbody><tr style=\"font-family:Roboto;font-size:15px;font-weight:bold;\"><td>CONTACT DETAILS<\/td><\/tr><tr><td>Ashvich Tower,<br>\nNo. 3, Developed Plots Industrial Estate, Perungudi,<br>\nChennai \u2013 600 096, Tamil Nadu, INDIA.<\/td><\/tr><\/tbody><\/table><\/figure>\n<\/div>\n<\/div>\n\n\n\n<h3 class=\"has-text-align-center\">SHAREHOLDERS GRIEVANCE REDRESSAL<\/h3>\n\n\n\n<p>For any assistance, request or instruction regarding transfer or transmission of shares, dematerialization of shares, change of address, non-receipt of annual report, dividend warrant, Refund of shares\/Dividend from Investor Education and Protection Fund (IEPF), any other query relating to the company, the investors may please write to the following address or e-mail ID :<\/p>\n\n\n\n<div class=\"wp-block-columns\">\n<div class=\"wp-block-column\" style=\"flex-basis:66.66%\">\n<figure class=\"wp-block-table is-style-stripes\">\n  <table>\n    <tbody>\n      <tr style=\"font-family:Roboto;font-size:15px;font-weight:bold;\">\n        <td>S.NO<\/td>\n        <td>NAME<\/td>\n        <td>DESIGNATION<\/td>\n      <\/tr>\n      <tr>\n        <td>01<\/td>\n        <td>Mr G Venkatram<\/td>\n        <td>Compliance Officer &amp; Nodal Officer &#8211; IEPF<\/td>\n      <\/tr>\n      <tr>\n        <td>02<\/td>\n        <td>Dr Sridhar Ganesan<\/td>\n        <td>Deputy Nodal Officer &#8211; IEPF<\/td>\n      <\/tr>\n      <tr>\n        <td>03<\/td>\n        <td>Ms J Swarnalakshmi<\/td>\n        <td>Deputy Nodal Officer &#8211; IEPF<\/td>\n      <\/tr>\n    <\/tbody>\n  <\/table>\n<\/figure>\n\n\n\n<p><\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column\" style=\"flex-basis:33.33%\">\n<figure class=\"wp-block-table is-style-stripes\">\n  <table class=\"has-fixed-layout\">\n    <tbody>\n      <tr style=\"font-family:Roboto;font-size:15px;font-weight:bold;\">\n        <td>CONTACT DETAILS<\/td>\n      <\/tr>\n      <tr>\n        <td>\n          Caplin Point Laboratories Ltd,<br>\n          3rd Floor, Ashvich Towers,<br>\n          No 3, Developed Plots Industrial Estate, Perungudi,<br>\n          Chennai \u2013 600 096<br>\n          Ph: +91 44 2496 8000<br>\n          Mob: +91 7094481436<br>\n          E-mail: investor@caplinpoint.net\n        <\/td>\n      <\/tr>\n    <\/tbody>\n  <\/table>\n<\/figure>\n<\/div>\n<\/div>\n\n\n\n<h3 class=\"has-text-align-center\">REGISTRAR AND SHARE TRANSFER AGENTS<\/h3>\n\n\n\n<div class=\"wp-block-columns\">\n<div class=\"wp-block-column\" style=\"flex-basis:66.66%\">\n<p>Integrated Registry Management Services Private Limited,<br> II Floor &#8220;Kences Towers&#8221;,<br> No.1 Ramakrishna Street North Usman Road, T Nagar,<br>Chennai &#8211; 600 017<br> Phone: 044 &#8211; 28140801 &#8211; 803<br> Fax: 044 &#8211; 28142479<br> Email: srirams@integratedindia.in<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column\" style=\"flex-basis:86.3%\"><\/div>\n<\/div>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>CAPLIN POINT LABORATORIES LIMITED CONTACT DETAILS OF KEY MANAGERIAL PERSONNEL\u2019S AUTHORISED FOR THE PURPOSE THE DETERMINING THE MATERIALITY OF AN EVENT OR INFORMATION AND MAKING DISCLOSURE TO THE STOCK EXCHANGE . (Pursuant to Regulation 30(5) of the SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015) S.NO NAME OF THE KMP DESIGNATION 01 Dr Sridhar Ganesan&#8230; <\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"full-width.php","meta":[],"_links":{"self":[{"href":"http:\/\/model1.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/pages\/420"}],"collection":[{"href":"http:\/\/model1.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"http:\/\/model1.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"http:\/\/model1.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/model1.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/comments?post=420"}],"version-history":[{"count":19,"href":"http:\/\/model1.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/pages\/420\/revisions"}],"predecessor-version":[{"id":20904,"href":"http:\/\/model1.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/pages\/420\/revisions\/20904"}],"wp:attachment":[{"href":"http:\/\/model1.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/media?parent=420"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}